Italia markets closed
FTSE MIB
33.812,44 +41,37 (+0,12%) Dow Jones
40.589,34 +654,27 (+1,64%) Nasdaq
17.357,88 +176,16 (+1,03%) Nikkei 225
37.667,41 -202,10 (-0,53%) Petrolio
76,44 -1,84 (-2,35%) Bitcoin EUR
62.616,29 +893,11 (+1,45%)
Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
Alla chiusura: 04:00PM EDT
Dopo ore:
| Chiusura precedente | 334,30 |
| Aperto | 334,56 |
| Denaro | 334,66 x 100 |
| Domanda | 335,12 x 100 |
| Min-Max giorno | 333,33 - 338,83 |
| Intervallo di 52 settimane | 228,21 - 346,85 |
| Volume | |
| Media Volume | 2.450.198 |
| Capitalizzazione | 179,625B |
| Beta (mensile su 5 anni) | 0,58 |
| Rapporto PE (ttm) | 47,84 |
| EPS (ttm) | 7,00 |
| Prossima data utili | 01 ago 2024 - 05 ago 2024 |
| Rendimento e dividendo (futuro) | 9,00 (2,69%) |
| Data ex dividendo | 16 mag 2024 |
| Stima target 1A | 320,24 |
GlobeNewswireGlobal CAR T-cell Therapy Market Projected to Reach $83 Billion by 2032
PALM BEACH, Fla., Oct. 12, 2023 (GLOBE NEWSWIRE) -- FinancialNewsMedia.com News Commentary - Significant influences driving the CAR T-cell therapy market is a rising demand for model therapeutics for treatment of cancer, increase in prevalence of cancer and an escalating awareness of CAR T-cell therapy medicines. The CAR T-cell therapy market is currently going through a rapid expansion, owing to rapidly expanding clinical trial activities and recent commercialization of CAR-T cell therapy, whic
© 2024 Yahoo. Tutti i diritti riservati.